Global Artificial Pancreas Device System

Artificial Pancreas Device System Comprehensive Study by Type (Control-to-Range (CTR) System, Threshold Suspended Device System, Control - to - Target (CTT) System, Bi-Hormonal Control System, Insulin-Only System), Components (Insulin Pump, Continuous Blood Glucose Monitor), Distribution Channel (Online, Offline), Age Group (Children, Adults), Treatment Type (Type 1 Diabetes, Type 2 Diabetes) Players and Region - Global Market Outlook to 2028

Artificial Pancreas Device System Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Artificial Pancreas Device System Market?

Artificial organs are man-made bio-artificial organs that are implanted in the body to replace or support natural organs. Artificial organs mainly include artificial heart, pancreas, kidney, and cochlear implants. They consist of biocompatible materials such as polymers, biologicals, ceramics, and metals. Various technologies such as sensors, biomaterials, and innovative delivery systems are implanted in the artificial pancreas. In addition, the artificial pancreas performs the same function as the natural pancreas and helps the patient to live a high-quality life. The artificial pancreatic device system is able to almost perfectly replicate the regulatory functions of glucose in a healthy organic pancreas. These systems generally include three types of devices: an insulin pump or infuser, a constant glucose monitoring system, and a glucometer or other blood glucose meter. The meter is required to support the calibration of the CGM. This can also be done with a computer that can manage an algorithm to control the CGM using values derived from the blood glucose meter. An artificial pancreatic device system is usually a closed system that follows an automated process for delivering insulin to a patient. It can, therefore, be completely autonomous and work without manual input, similar to an organic pancreas.

Highlights from Artificial Pancreas Device System Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledMedtronic (Ireland), Johnson & Johnson (United States), TypeZero Technologies (United States), Tandem Diabetes Care (United States), Pancreum (United States), Insulet Corporation (United States), Beta Bionics, Inc. (United States), Animas Corporation (United States), Bigfoot Biomedical (United States), NIKKISO Co., Ltd. (Japan), Admetsys Corporation (United States) and Dexcom (United States)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Artificial Pancreas Device System market throughout the forecasted period.

Medtronic (Ireland), Johnson & Johnson (United States), TypeZero Technologies (United States), Tandem Diabetes Care (United States), Pancreum (United States), Insulet Corporation (United States), Beta Bionics, Inc. (United States), Animas Corporation (United States), Bigfoot Biomedical (United States), NIKKISO Co., Ltd. (Japan), Admetsys Corporation (United States) and Dexcom (United States) are some of the key players profiled in the study.

Artificial Pancreas Device System Market Segmentation:
ScopeSub-Segments
TypeControl-to-Range (CTR) System, Threshold Suspended Device System, Control - to - Target (CTT) System, Bi-Hormonal Control System and Insulin-Only System
ComponentsInsulin Pump,Continuous Blood Glucose Monitor
Distribution ChannelOnline,Offline
Age GroupChildren,Adults
Treatment TypeType 1 Diabetes,Type 2 Diabetes


On the basis of geography, the market of Artificial Pancreas Device System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase in the Awareness of the Population and Collaboration of FDA with Private Institutes and A Rise in Fully Automated System Which Minimizes Patient Intervention

Market Growth Drivers:
Rising Prevalence of Type-1 Diabetes, Increase In Demand for Organ Transplant and Growing Prevalence of Pancreatic Disorders, Increasing Demand for Insulin Self-Administration and Rising Geriatric Population

Challenges:
Growing Awareness about the Side Effects of the Treatment Modality

Restraints:
Lack of Skilled Professionals in Underdeveloped Regions and Ineffectiveness of This Technology in Treating Athletic Diabetes

Opportunities:
Increase in Funds Provided By the Government for Providing a Better Quality of Treatment and R&D In the Field Of Medical Equipment Is Anticipated To Create New Opportunities

Key Target Audience
Manufacturers of Artificial Pancreas Device System, Suppliers and Distributors Artificial Pancreas Device System, End-Users, Potential Investors, Market Research Firms and Others

Market Leaders & Development Strategies
In February 2023, Insulet Corporation (Insulet or Company), a global leader in tubeless insulin pump technology under the Omnipod® brand of products, acquired the assets of Automated Glucose Control LLC (AGC) of Palo Alto, California. Develops and commercializes best-in-class automated insulin delivery technology.
In April 2023, Medtronic plc., a global leader in medical technology of the US Food and Drug Administration (FDA), approved the MiniMed™ 780G system with Fingerstick-free Guardian 4 sensor in SmartGuard™ technology. This milestone has been approved as the only system with meal detection technology that provides automatic adjustments and corrections to glucose levels every 5 minutes for both basal (background) and bolus (mealtime) insulin needs. The system provides insulin to account for cases where the user sometimes forgets to take a bolus or underestimates the number of carbohydrates in a meal.


Report Objectives / Segmentation Covered

By Type
  • Control-to-Range (CTR) System
  • Threshold Suspended Device System
  • Control - to - Target (CTT) System
  • Bi-Hormonal Control System
  • Insulin-Only System
By Components
  • Insulin Pump
  • Continuous Blood Glucose Monitor

By Distribution Channel
  • Online
  • Offline

By Age Group
  • Children
  • Adults

By Treatment Type
  • Type 1 Diabetes
  • Type 2 Diabetes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Type-1 Diabetes
      • 3.2.2. Increase In Demand for Organ Transplant and Growing Prevalence of Pancreatic Disorders
      • 3.2.3. Increasing Demand for Insulin Self-Administration
      • 3.2.4. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Growing Awareness about the Side Effects of the Treatment Modality
    • 3.4. Market Trends
      • 3.4.1. Increase in the Awareness of the Population and Collaboration of FDA with Private Institutes
      • 3.4.2. A Rise in Fully Automated System Which Minimizes Patient Intervention
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Pancreas Device System, by Type, Components, Distribution Channel, Age Group, Treatment Type and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial Pancreas Device System (Value)
      • 5.2.1. Global Artificial Pancreas Device System by: Type (Value)
        • 5.2.1.1. Control-to-Range (CTR) System
        • 5.2.1.2. Threshold Suspended Device System
        • 5.2.1.3. Control - to - Target (CTT) System
        • 5.2.1.4. Bi-Hormonal Control System
        • 5.2.1.5. Insulin-Only System
      • 5.2.2. Global Artificial Pancreas Device System by: Components (Value)
        • 5.2.2.1. Insulin Pump
        • 5.2.2.2. Continuous Blood Glucose Monitor
      • 5.2.3. Global Artificial Pancreas Device System by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Artificial Pancreas Device System by: Age Group (Value)
        • 5.2.4.1. Children
        • 5.2.4.2. Adults
      • 5.2.5. Global Artificial Pancreas Device System by: Treatment Type (Value)
        • 5.2.5.1. Type 1 Diabetes
        • 5.2.5.2. Type 2 Diabetes
      • 5.2.6. Global Artificial Pancreas Device System Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Artificial Pancreas Device System (Volume)
      • 5.3.1. Global Artificial Pancreas Device System by: Type (Volume)
        • 5.3.1.1. Control-to-Range (CTR) System
        • 5.3.1.2. Threshold Suspended Device System
        • 5.3.1.3. Control - to - Target (CTT) System
        • 5.3.1.4. Bi-Hormonal Control System
        • 5.3.1.5. Insulin-Only System
      • 5.3.2. Global Artificial Pancreas Device System by: Components (Volume)
        • 5.3.2.1. Insulin Pump
        • 5.3.2.2. Continuous Blood Glucose Monitor
      • 5.3.3. Global Artificial Pancreas Device System by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Artificial Pancreas Device System by: Age Group (Volume)
        • 5.3.4.1. Children
        • 5.3.4.2. Adults
      • 5.3.5. Global Artificial Pancreas Device System by: Treatment Type (Volume)
        • 5.3.5.1. Type 1 Diabetes
        • 5.3.5.2. Type 2 Diabetes
      • 5.3.6. Global Artificial Pancreas Device System Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Artificial Pancreas Device System (Price)
      • 5.4.1. Global Artificial Pancreas Device System by: Type (Price)
  • 6. Artificial Pancreas Device System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. TypeZero Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Tandem Diabetes Care (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pancreum (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Insulet Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Beta Bionics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Animas Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bigfoot Biomedical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. NIKKISO Co., Ltd. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Admetsys Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Dexcom (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Artificial Pancreas Device System Sale, by Type, Components, Distribution Channel, Age Group, Treatment Type and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial Pancreas Device System (Value)
      • 7.2.1. Global Artificial Pancreas Device System by: Type (Value)
        • 7.2.1.1. Control-to-Range (CTR) System
        • 7.2.1.2. Threshold Suspended Device System
        • 7.2.1.3. Control - to - Target (CTT) System
        • 7.2.1.4. Bi-Hormonal Control System
        • 7.2.1.5. Insulin-Only System
      • 7.2.2. Global Artificial Pancreas Device System by: Components (Value)
        • 7.2.2.1. Insulin Pump
        • 7.2.2.2. Continuous Blood Glucose Monitor
      • 7.2.3. Global Artificial Pancreas Device System by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Artificial Pancreas Device System by: Age Group (Value)
        • 7.2.4.1. Children
        • 7.2.4.2. Adults
      • 7.2.5. Global Artificial Pancreas Device System by: Treatment Type (Value)
        • 7.2.5.1. Type 1 Diabetes
        • 7.2.5.2. Type 2 Diabetes
      • 7.2.6. Global Artificial Pancreas Device System Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Artificial Pancreas Device System (Volume)
      • 7.3.1. Global Artificial Pancreas Device System by: Type (Volume)
        • 7.3.1.1. Control-to-Range (CTR) System
        • 7.3.1.2. Threshold Suspended Device System
        • 7.3.1.3. Control - to - Target (CTT) System
        • 7.3.1.4. Bi-Hormonal Control System
        • 7.3.1.5. Insulin-Only System
      • 7.3.2. Global Artificial Pancreas Device System by: Components (Volume)
        • 7.3.2.1. Insulin Pump
        • 7.3.2.2. Continuous Blood Glucose Monitor
      • 7.3.3. Global Artificial Pancreas Device System by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Artificial Pancreas Device System by: Age Group (Volume)
        • 7.3.4.1. Children
        • 7.3.4.2. Adults
      • 7.3.5. Global Artificial Pancreas Device System by: Treatment Type (Volume)
        • 7.3.5.1. Type 1 Diabetes
        • 7.3.5.2. Type 2 Diabetes
      • 7.3.6. Global Artificial Pancreas Device System Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Artificial Pancreas Device System (Price)
      • 7.4.1. Global Artificial Pancreas Device System by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Pancreas Device System: by Type(USD Million)
  • Table 2. Artificial Pancreas Device System Control-to-Range (CTR) System , by Region USD Million (2017-2022)
  • Table 3. Artificial Pancreas Device System Threshold Suspended Device System , by Region USD Million (2017-2022)
  • Table 4. Artificial Pancreas Device System Control - to - Target (CTT) System , by Region USD Million (2017-2022)
  • Table 5. Artificial Pancreas Device System Bi-Hormonal Control System , by Region USD Million (2017-2022)
  • Table 6. Artificial Pancreas Device System Insulin-Only System , by Region USD Million (2017-2022)
  • Table 7. Artificial Pancreas Device System: by Components(USD Million)
  • Table 8. Artificial Pancreas Device System Insulin Pump , by Region USD Million (2017-2022)
  • Table 9. Artificial Pancreas Device System Continuous Blood Glucose Monitor , by Region USD Million (2017-2022)
  • Table 10. Artificial Pancreas Device System: by Distribution Channel(USD Million)
  • Table 11. Artificial Pancreas Device System Online , by Region USD Million (2017-2022)
  • Table 12. Artificial Pancreas Device System Offline , by Region USD Million (2017-2022)
  • Table 13. Artificial Pancreas Device System: by Age Group(USD Million)
  • Table 14. Artificial Pancreas Device System Children , by Region USD Million (2017-2022)
  • Table 15. Artificial Pancreas Device System Adults , by Region USD Million (2017-2022)
  • Table 16. Artificial Pancreas Device System: by Treatment Type(USD Million)
  • Table 17. Artificial Pancreas Device System Type 1 Diabetes , by Region USD Million (2017-2022)
  • Table 18. Artificial Pancreas Device System Type 2 Diabetes , by Region USD Million (2017-2022)
  • Table 19. South America Artificial Pancreas Device System, by Country USD Million (2017-2022)
  • Table 20. South America Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 21. South America Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 22. South America Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 23. South America Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 24. South America Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 25. Brazil Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 26. Brazil Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 27. Brazil Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 28. Brazil Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 29. Brazil Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 30. Argentina Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 31. Argentina Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 32. Argentina Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 33. Argentina Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 34. Argentina Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 35. Rest of South America Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 36. Rest of South America Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 37. Rest of South America Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 38. Rest of South America Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 39. Rest of South America Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 40. Asia Pacific Artificial Pancreas Device System, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 42. Asia Pacific Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 43. Asia Pacific Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 44. Asia Pacific Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 45. Asia Pacific Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 46. China Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 47. China Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 48. China Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 49. China Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 50. China Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 51. Japan Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 52. Japan Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 53. Japan Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 54. Japan Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 55. Japan Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 56. India Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 57. India Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 58. India Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 59. India Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 60. India Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 61. South Korea Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 62. South Korea Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 63. South Korea Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 64. South Korea Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 65. South Korea Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 66. Taiwan Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 67. Taiwan Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 68. Taiwan Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 69. Taiwan Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 70. Taiwan Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 71. Australia Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 72. Australia Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 73. Australia Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 74. Australia Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 75. Australia Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 81. Europe Artificial Pancreas Device System, by Country USD Million (2017-2022)
  • Table 82. Europe Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 83. Europe Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 84. Europe Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 85. Europe Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 86. Europe Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 87. Germany Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 88. Germany Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 89. Germany Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 90. Germany Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 91. Germany Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 92. France Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 93. France Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 94. France Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 95. France Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 96. France Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 97. Italy Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 98. Italy Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 99. Italy Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 100. Italy Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 101. Italy Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 102. United Kingdom Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 103. United Kingdom Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 104. United Kingdom Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 105. United Kingdom Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 106. United Kingdom Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 107. Netherlands Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 108. Netherlands Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 109. Netherlands Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 110. Netherlands Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 111. Netherlands Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 112. Rest of Europe Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 113. Rest of Europe Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 114. Rest of Europe Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 115. Rest of Europe Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 116. Rest of Europe Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 117. MEA Artificial Pancreas Device System, by Country USD Million (2017-2022)
  • Table 118. MEA Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 119. MEA Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 120. MEA Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 121. MEA Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 122. MEA Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 123. Middle East Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 124. Middle East Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 125. Middle East Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 126. Middle East Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 127. Middle East Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 128. Africa Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 129. Africa Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 130. Africa Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 131. Africa Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 132. Africa Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 133. North America Artificial Pancreas Device System, by Country USD Million (2017-2022)
  • Table 134. North America Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 135. North America Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 136. North America Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 137. North America Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 138. North America Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 139. United States Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 140. United States Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 141. United States Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 142. United States Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 143. United States Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 144. Canada Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 145. Canada Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 146. Canada Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 147. Canada Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 148. Canada Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 149. Mexico Artificial Pancreas Device System, by Type USD Million (2017-2022)
  • Table 150. Mexico Artificial Pancreas Device System, by Components USD Million (2017-2022)
  • Table 151. Mexico Artificial Pancreas Device System, by Distribution Channel USD Million (2017-2022)
  • Table 152. Mexico Artificial Pancreas Device System, by Age Group USD Million (2017-2022)
  • Table 153. Mexico Artificial Pancreas Device System, by Treatment Type USD Million (2017-2022)
  • Table 154. Artificial Pancreas Device System Sales: by Type(K Units)
  • Table 155. Artificial Pancreas Device System Sales Control-to-Range (CTR) System , by Region K Units (2017-2022)
  • Table 156. Artificial Pancreas Device System Sales Threshold Suspended Device System , by Region K Units (2017-2022)
  • Table 157. Artificial Pancreas Device System Sales Control - to - Target (CTT) System , by Region K Units (2017-2022)
  • Table 158. Artificial Pancreas Device System Sales Bi-Hormonal Control System , by Region K Units (2017-2022)
  • Table 159. Artificial Pancreas Device System Sales Insulin-Only System , by Region K Units (2017-2022)
  • Table 160. Artificial Pancreas Device System Sales: by Components(K Units)
  • Table 161. Artificial Pancreas Device System Sales Insulin Pump , by Region K Units (2017-2022)
  • Table 162. Artificial Pancreas Device System Sales Continuous Blood Glucose Monitor , by Region K Units (2017-2022)
  • Table 163. Artificial Pancreas Device System Sales: by Distribution Channel(K Units)
  • Table 164. Artificial Pancreas Device System Sales Online , by Region K Units (2017-2022)
  • Table 165. Artificial Pancreas Device System Sales Offline , by Region K Units (2017-2022)
  • Table 166. Artificial Pancreas Device System Sales: by Age Group(K Units)
  • Table 167. Artificial Pancreas Device System Sales Children , by Region K Units (2017-2022)
  • Table 168. Artificial Pancreas Device System Sales Adults , by Region K Units (2017-2022)
  • Table 169. Artificial Pancreas Device System Sales: by Treatment Type(K Units)
  • Table 170. Artificial Pancreas Device System Sales Type 1 Diabetes , by Region K Units (2017-2022)
  • Table 171. Artificial Pancreas Device System Sales Type 2 Diabetes , by Region K Units (2017-2022)
  • Table 172. South America Artificial Pancreas Device System Sales, by Country K Units (2017-2022)
  • Table 173. South America Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 174. South America Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 175. South America Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 176. South America Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 177. South America Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 178. Brazil Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 179. Brazil Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 180. Brazil Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 181. Brazil Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 182. Brazil Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 183. Argentina Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 184. Argentina Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 185. Argentina Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 186. Argentina Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 187. Argentina Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 188. Rest of South America Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 189. Rest of South America Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 190. Rest of South America Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 191. Rest of South America Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 192. Rest of South America Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 193. Asia Pacific Artificial Pancreas Device System Sales, by Country K Units (2017-2022)
  • Table 194. Asia Pacific Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 195. Asia Pacific Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 196. Asia Pacific Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 197. Asia Pacific Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 198. Asia Pacific Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 199. China Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 200. China Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 201. China Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 202. China Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 203. China Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 204. Japan Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 205. Japan Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 206. Japan Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 207. Japan Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 208. Japan Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 209. India Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 210. India Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 211. India Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 212. India Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 213. India Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 214. South Korea Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 215. South Korea Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 216. South Korea Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 217. South Korea Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 218. South Korea Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 219. Taiwan Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 220. Taiwan Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 221. Taiwan Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 222. Taiwan Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 223. Taiwan Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 224. Australia Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 225. Australia Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 226. Australia Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 227. Australia Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 228. Australia Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 229. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 230. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 231. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 232. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 233. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 234. Europe Artificial Pancreas Device System Sales, by Country K Units (2017-2022)
  • Table 235. Europe Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 236. Europe Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 237. Europe Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 238. Europe Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 239. Europe Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 240. Germany Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 241. Germany Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 242. Germany Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 243. Germany Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 244. Germany Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 245. France Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 246. France Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 247. France Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 248. France Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 249. France Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 250. Italy Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 251. Italy Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 252. Italy Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 253. Italy Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 254. Italy Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 255. United Kingdom Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 256. United Kingdom Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 257. United Kingdom Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 258. United Kingdom Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 259. United Kingdom Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 260. Netherlands Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 261. Netherlands Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 262. Netherlands Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 263. Netherlands Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 264. Netherlands Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 265. Rest of Europe Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 266. Rest of Europe Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 267. Rest of Europe Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 268. Rest of Europe Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 269. Rest of Europe Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 270. MEA Artificial Pancreas Device System Sales, by Country K Units (2017-2022)
  • Table 271. MEA Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 272. MEA Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 273. MEA Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 274. MEA Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 275. MEA Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 276. Middle East Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 277. Middle East Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 278. Middle East Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 279. Middle East Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 280. Middle East Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 281. Africa Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 282. Africa Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 283. Africa Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 284. Africa Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 285. Africa Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 286. North America Artificial Pancreas Device System Sales, by Country K Units (2017-2022)
  • Table 287. North America Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 288. North America Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 289. North America Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 290. North America Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 291. North America Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 292. United States Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 293. United States Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 294. United States Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 295. United States Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 296. United States Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 297. Canada Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 298. Canada Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 299. Canada Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 300. Canada Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 301. Canada Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 302. Mexico Artificial Pancreas Device System Sales, by Type K Units (2017-2022)
  • Table 303. Mexico Artificial Pancreas Device System Sales, by Components K Units (2017-2022)
  • Table 304. Mexico Artificial Pancreas Device System Sales, by Distribution Channel K Units (2017-2022)
  • Table 305. Mexico Artificial Pancreas Device System Sales, by Age Group K Units (2017-2022)
  • Table 306. Mexico Artificial Pancreas Device System Sales, by Treatment Type K Units (2017-2022)
  • Table 307. Artificial Pancreas Device System: by Type(USD/Units)
  • Table 308. Company Basic Information, Sales Area and Its Competitors
  • Table 309. Company Basic Information, Sales Area and Its Competitors
  • Table 310. Company Basic Information, Sales Area and Its Competitors
  • Table 311. Company Basic Information, Sales Area and Its Competitors
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Artificial Pancreas Device System: by Type(USD Million)
  • Table 321. Artificial Pancreas Device System Control-to-Range (CTR) System , by Region USD Million (2023-2028)
  • Table 322. Artificial Pancreas Device System Threshold Suspended Device System , by Region USD Million (2023-2028)
  • Table 323. Artificial Pancreas Device System Control - to - Target (CTT) System , by Region USD Million (2023-2028)
  • Table 324. Artificial Pancreas Device System Bi-Hormonal Control System , by Region USD Million (2023-2028)
  • Table 325. Artificial Pancreas Device System Insulin-Only System , by Region USD Million (2023-2028)
  • Table 326. Artificial Pancreas Device System: by Components(USD Million)
  • Table 327. Artificial Pancreas Device System Insulin Pump , by Region USD Million (2023-2028)
  • Table 328. Artificial Pancreas Device System Continuous Blood Glucose Monitor , by Region USD Million (2023-2028)
  • Table 329. Artificial Pancreas Device System: by Distribution Channel(USD Million)
  • Table 330. Artificial Pancreas Device System Online , by Region USD Million (2023-2028)
  • Table 331. Artificial Pancreas Device System Offline , by Region USD Million (2023-2028)
  • Table 332. Artificial Pancreas Device System: by Age Group(USD Million)
  • Table 333. Artificial Pancreas Device System Children , by Region USD Million (2023-2028)
  • Table 334. Artificial Pancreas Device System Adults , by Region USD Million (2023-2028)
  • Table 335. Artificial Pancreas Device System: by Treatment Type(USD Million)
  • Table 336. Artificial Pancreas Device System Type 1 Diabetes , by Region USD Million (2023-2028)
  • Table 337. Artificial Pancreas Device System Type 2 Diabetes , by Region USD Million (2023-2028)
  • Table 338. South America Artificial Pancreas Device System, by Country USD Million (2023-2028)
  • Table 339. South America Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 340. South America Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 341. South America Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 342. South America Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 343. South America Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 344. Brazil Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 345. Brazil Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 346. Brazil Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 347. Brazil Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 348. Brazil Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 349. Argentina Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 350. Argentina Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 351. Argentina Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 352. Argentina Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 353. Argentina Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 354. Rest of South America Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 355. Rest of South America Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 356. Rest of South America Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 357. Rest of South America Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 358. Rest of South America Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 359. Asia Pacific Artificial Pancreas Device System, by Country USD Million (2023-2028)
  • Table 360. Asia Pacific Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 361. Asia Pacific Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 362. Asia Pacific Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 363. Asia Pacific Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 364. Asia Pacific Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 365. China Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 366. China Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 367. China Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 368. China Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 369. China Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 370. Japan Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 371. Japan Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 372. Japan Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 373. Japan Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 374. Japan Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 375. India Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 376. India Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 377. India Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 378. India Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 379. India Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 380. South Korea Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 381. South Korea Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 382. South Korea Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 383. South Korea Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 384. South Korea Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 385. Taiwan Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 386. Taiwan Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 387. Taiwan Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 388. Taiwan Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 389. Taiwan Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 390. Australia Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 391. Australia Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 392. Australia Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 393. Australia Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 394. Australia Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 395. Rest of Asia-Pacific Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 396. Rest of Asia-Pacific Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 397. Rest of Asia-Pacific Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 398. Rest of Asia-Pacific Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 399. Rest of Asia-Pacific Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 400. Europe Artificial Pancreas Device System, by Country USD Million (2023-2028)
  • Table 401. Europe Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 402. Europe Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 403. Europe Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 404. Europe Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 405. Europe Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 406. Germany Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 407. Germany Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 408. Germany Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 409. Germany Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 410. Germany Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 411. France Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 412. France Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 413. France Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 414. France Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 415. France Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 416. Italy Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 417. Italy Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 418. Italy Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 419. Italy Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 420. Italy Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 421. United Kingdom Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 422. United Kingdom Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 423. United Kingdom Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 424. United Kingdom Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 425. United Kingdom Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 426. Netherlands Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 427. Netherlands Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 428. Netherlands Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 429. Netherlands Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 430. Netherlands Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 431. Rest of Europe Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 432. Rest of Europe Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 433. Rest of Europe Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 434. Rest of Europe Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 435. Rest of Europe Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 436. MEA Artificial Pancreas Device System, by Country USD Million (2023-2028)
  • Table 437. MEA Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 438. MEA Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 439. MEA Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 440. MEA Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 441. MEA Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 442. Middle East Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 443. Middle East Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 444. Middle East Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 445. Middle East Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 446. Middle East Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 447. Africa Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 448. Africa Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 449. Africa Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 450. Africa Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 451. Africa Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 452. North America Artificial Pancreas Device System, by Country USD Million (2023-2028)
  • Table 453. North America Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 454. North America Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 455. North America Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 456. North America Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 457. North America Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 458. United States Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 459. United States Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 460. United States Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 461. United States Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 462. United States Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 463. Canada Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 464. Canada Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 465. Canada Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 466. Canada Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 467. Canada Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 468. Mexico Artificial Pancreas Device System, by Type USD Million (2023-2028)
  • Table 469. Mexico Artificial Pancreas Device System, by Components USD Million (2023-2028)
  • Table 470. Mexico Artificial Pancreas Device System, by Distribution Channel USD Million (2023-2028)
  • Table 471. Mexico Artificial Pancreas Device System, by Age Group USD Million (2023-2028)
  • Table 472. Mexico Artificial Pancreas Device System, by Treatment Type USD Million (2023-2028)
  • Table 473. Artificial Pancreas Device System Sales: by Type(K Units)
  • Table 474. Artificial Pancreas Device System Sales Control-to-Range (CTR) System , by Region K Units (2023-2028)
  • Table 475. Artificial Pancreas Device System Sales Threshold Suspended Device System , by Region K Units (2023-2028)
  • Table 476. Artificial Pancreas Device System Sales Control - to - Target (CTT) System , by Region K Units (2023-2028)
  • Table 477. Artificial Pancreas Device System Sales Bi-Hormonal Control System , by Region K Units (2023-2028)
  • Table 478. Artificial Pancreas Device System Sales Insulin-Only System , by Region K Units (2023-2028)
  • Table 479. Artificial Pancreas Device System Sales: by Components(K Units)
  • Table 480. Artificial Pancreas Device System Sales Insulin Pump , by Region K Units (2023-2028)
  • Table 481. Artificial Pancreas Device System Sales Continuous Blood Glucose Monitor , by Region K Units (2023-2028)
  • Table 482. Artificial Pancreas Device System Sales: by Distribution Channel(K Units)
  • Table 483. Artificial Pancreas Device System Sales Online , by Region K Units (2023-2028)
  • Table 484. Artificial Pancreas Device System Sales Offline , by Region K Units (2023-2028)
  • Table 485. Artificial Pancreas Device System Sales: by Age Group(K Units)
  • Table 486. Artificial Pancreas Device System Sales Children , by Region K Units (2023-2028)
  • Table 487. Artificial Pancreas Device System Sales Adults , by Region K Units (2023-2028)
  • Table 488. Artificial Pancreas Device System Sales: by Treatment Type(K Units)
  • Table 489. Artificial Pancreas Device System Sales Type 1 Diabetes , by Region K Units (2023-2028)
  • Table 490. Artificial Pancreas Device System Sales Type 2 Diabetes , by Region K Units (2023-2028)
  • Table 491. South America Artificial Pancreas Device System Sales, by Country K Units (2023-2028)
  • Table 492. South America Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 493. South America Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 494. South America Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 495. South America Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 496. South America Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 497. Brazil Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 498. Brazil Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 499. Brazil Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 500. Brazil Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 501. Brazil Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 502. Argentina Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 503. Argentina Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 504. Argentina Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 505. Argentina Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 506. Argentina Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 507. Rest of South America Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 508. Rest of South America Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 509. Rest of South America Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 510. Rest of South America Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 511. Rest of South America Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 512. Asia Pacific Artificial Pancreas Device System Sales, by Country K Units (2023-2028)
  • Table 513. Asia Pacific Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 514. Asia Pacific Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 515. Asia Pacific Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 516. Asia Pacific Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 517. Asia Pacific Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 518. China Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 519. China Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 520. China Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 521. China Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 522. China Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 523. Japan Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 524. Japan Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 525. Japan Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 526. Japan Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 527. Japan Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 528. India Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 529. India Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 530. India Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 531. India Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 532. India Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 533. South Korea Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 534. South Korea Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 535. South Korea Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 536. South Korea Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 537. South Korea Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 538. Taiwan Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 539. Taiwan Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 540. Taiwan Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 541. Taiwan Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 542. Taiwan Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 543. Australia Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 544. Australia Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 545. Australia Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 546. Australia Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 547. Australia Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 548. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 549. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 550. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 551. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 552. Rest of Asia-Pacific Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 553. Europe Artificial Pancreas Device System Sales, by Country K Units (2023-2028)
  • Table 554. Europe Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 555. Europe Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 556. Europe Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 557. Europe Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 558. Europe Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 559. Germany Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 560. Germany Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 561. Germany Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 562. Germany Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 563. Germany Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 564. France Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 565. France Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 566. France Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 567. France Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 568. France Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 569. Italy Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 570. Italy Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 571. Italy Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 572. Italy Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 573. Italy Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 574. United Kingdom Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 575. United Kingdom Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 576. United Kingdom Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 577. United Kingdom Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 578. United Kingdom Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 579. Netherlands Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 580. Netherlands Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 581. Netherlands Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 582. Netherlands Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 583. Netherlands Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 584. Rest of Europe Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 585. Rest of Europe Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 586. Rest of Europe Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 587. Rest of Europe Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 588. Rest of Europe Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 589. MEA Artificial Pancreas Device System Sales, by Country K Units (2023-2028)
  • Table 590. MEA Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 591. MEA Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 592. MEA Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 593. MEA Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 594. MEA Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 595. Middle East Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 596. Middle East Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 597. Middle East Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 598. Middle East Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 599. Middle East Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 600. Africa Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 601. Africa Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 602. Africa Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 603. Africa Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 604. Africa Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 605. North America Artificial Pancreas Device System Sales, by Country K Units (2023-2028)
  • Table 606. North America Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 607. North America Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 608. North America Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 609. North America Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 610. North America Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 611. United States Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 612. United States Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 613. United States Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 614. United States Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 615. United States Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 616. Canada Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 617. Canada Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 618. Canada Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 619. Canada Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 620. Canada Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 621. Mexico Artificial Pancreas Device System Sales, by Type K Units (2023-2028)
  • Table 622. Mexico Artificial Pancreas Device System Sales, by Components K Units (2023-2028)
  • Table 623. Mexico Artificial Pancreas Device System Sales, by Distribution Channel K Units (2023-2028)
  • Table 624. Mexico Artificial Pancreas Device System Sales, by Age Group K Units (2023-2028)
  • Table 625. Mexico Artificial Pancreas Device System Sales, by Treatment Type K Units (2023-2028)
  • Table 626. Artificial Pancreas Device System: by Type(USD/Units)
  • Table 627. Research Programs/Design for This Report
  • Table 628. Key Data Information from Secondary Sources
  • Table 629. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Pancreas Device System: by Type USD Million (2017-2022)
  • Figure 5. Global Artificial Pancreas Device System: by Components USD Million (2017-2022)
  • Figure 6. Global Artificial Pancreas Device System: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Artificial Pancreas Device System: by Age Group USD Million (2017-2022)
  • Figure 8. Global Artificial Pancreas Device System: by Treatment Type USD Million (2017-2022)
  • Figure 9. South America Artificial Pancreas Device System Share (%), by Country
  • Figure 10. Asia Pacific Artificial Pancreas Device System Share (%), by Country
  • Figure 11. Europe Artificial Pancreas Device System Share (%), by Country
  • Figure 12. MEA Artificial Pancreas Device System Share (%), by Country
  • Figure 13. North America Artificial Pancreas Device System Share (%), by Country
  • Figure 14. Global Artificial Pancreas Device System: by Type K Units (2017-2022)
  • Figure 15. Global Artificial Pancreas Device System: by Components K Units (2017-2022)
  • Figure 16. Global Artificial Pancreas Device System: by Distribution Channel K Units (2017-2022)
  • Figure 17. Global Artificial Pancreas Device System: by Age Group K Units (2017-2022)
  • Figure 18. Global Artificial Pancreas Device System: by Treatment Type K Units (2017-2022)
  • Figure 19. South America Artificial Pancreas Device System Share (%), by Country
  • Figure 20. Asia Pacific Artificial Pancreas Device System Share (%), by Country
  • Figure 21. Europe Artificial Pancreas Device System Share (%), by Country
  • Figure 22. MEA Artificial Pancreas Device System Share (%), by Country
  • Figure 23. North America Artificial Pancreas Device System Share (%), by Country
  • Figure 24. Global Artificial Pancreas Device System: by Type USD/Units (2017-2022)
  • Figure 25. Global Artificial Pancreas Device System share by Players 2022 (%)
  • Figure 26. Global Artificial Pancreas Device System share by Players (Top 3) 2022(%)
  • Figure 27. Global Artificial Pancreas Device System share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 31. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 32. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 33. TypeZero Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 34. TypeZero Technologies (United States) Revenue: by Geography 2022
  • Figure 35. Tandem Diabetes Care (United States) Revenue, Net Income and Gross profit
  • Figure 36. Tandem Diabetes Care (United States) Revenue: by Geography 2022
  • Figure 37. Pancreum (United States) Revenue, Net Income and Gross profit
  • Figure 38. Pancreum (United States) Revenue: by Geography 2022
  • Figure 39. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Insulet Corporation (United States) Revenue: by Geography 2022
  • Figure 41. Beta Bionics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Beta Bionics, Inc. (United States) Revenue: by Geography 2022
  • Figure 43. Animas Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Animas Corporation (United States) Revenue: by Geography 2022
  • Figure 45. Bigfoot Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 46. Bigfoot Biomedical (United States) Revenue: by Geography 2022
  • Figure 47. NIKKISO Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 48. NIKKISO Co., Ltd. (Japan) Revenue: by Geography 2022
  • Figure 49. Admetsys Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 50. Admetsys Corporation (United States) Revenue: by Geography 2022
  • Figure 51. Dexcom (United States) Revenue, Net Income and Gross profit
  • Figure 52. Dexcom (United States) Revenue: by Geography 2022
  • Figure 53. Global Artificial Pancreas Device System: by Type USD Million (2023-2028)
  • Figure 54. Global Artificial Pancreas Device System: by Components USD Million (2023-2028)
  • Figure 55. Global Artificial Pancreas Device System: by Distribution Channel USD Million (2023-2028)
  • Figure 56. Global Artificial Pancreas Device System: by Age Group USD Million (2023-2028)
  • Figure 57. Global Artificial Pancreas Device System: by Treatment Type USD Million (2023-2028)
  • Figure 58. South America Artificial Pancreas Device System Share (%), by Country
  • Figure 59. Asia Pacific Artificial Pancreas Device System Share (%), by Country
  • Figure 60. Europe Artificial Pancreas Device System Share (%), by Country
  • Figure 61. MEA Artificial Pancreas Device System Share (%), by Country
  • Figure 62. North America Artificial Pancreas Device System Share (%), by Country
  • Figure 63. Global Artificial Pancreas Device System: by Type K Units (2023-2028)
  • Figure 64. Global Artificial Pancreas Device System: by Components K Units (2023-2028)
  • Figure 65. Global Artificial Pancreas Device System: by Distribution Channel K Units (2023-2028)
  • Figure 66. Global Artificial Pancreas Device System: by Age Group K Units (2023-2028)
  • Figure 67. Global Artificial Pancreas Device System: by Treatment Type K Units (2023-2028)
  • Figure 68. South America Artificial Pancreas Device System Share (%), by Country
  • Figure 69. Asia Pacific Artificial Pancreas Device System Share (%), by Country
  • Figure 70. Europe Artificial Pancreas Device System Share (%), by Country
  • Figure 71. MEA Artificial Pancreas Device System Share (%), by Country
  • Figure 72. North America Artificial Pancreas Device System Share (%), by Country
  • Figure 73. Global Artificial Pancreas Device System: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Johnson & Johnson (United States)
  • TypeZero Technologies (United States)
  • Tandem Diabetes Care (United States)
  • Pancreum (United States)
  • Insulet Corporation (United States)
  • Beta Bionics, Inc. (United States)
  • Animas Corporation (United States)
  • Bigfoot Biomedical (United States)
  • NIKKISO Co., Ltd. (Japan)
  • Admetsys Corporation (United States)
  • Dexcom (United States)
Select User Access Type

Key Highlights of Report


Oct 2023 218 Pages 90 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Pancreas Device System Quantitative research analysis
Global Artificial Pancreas Device System Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rising Prevalence of Type-1 Diabetes " is seen as one of major growth factors of Artificial Pancreas Device System Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Artificial Pancreas Device System market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Artificial Pancreas Device System Report?

Have a Query? Click Here

Other Related Reports

Wireless Stethoscope Comprehensive Study by Type (Bluetooth Connect, WIFI Connect), Application (Teaching, Hospitals, Veterinary, Cardiology), Patient Type (Human, Veterinary), End Users (Hospitals, ...
$ 3450
Medical X-ray Comprehensive Study by Type (Flat Panel Detectors, Line Scan Detectors, Computed Radiography Detectors, Charge Coupled Device Detector), Application (Cardiovascular, Respiratory, Dental...
$ 3750
Laser Power Meter Comprehensive Study by Type (Thermopile Detectors, Photodiode Detectors, Pyroelectric Energy Sensors), Application (Education, Industrial, Scientific, Others), Distribution Channel ...
$ 3500
Single-use Bioprocessing Comprehensive Study by Type (Media Bags and Containers, Filtration Assemblies, Single-use Bioreactors, Disposable Mixers, Others), Application (Monoclonal Antibody Production...
$ 3750
Medical Imaging Equipment Comprehensive Study by Type (Magnetic Resonance (MRI), Computed Tomography (CT), Radiology (X-Ray), Ultrasound (US), Nuclear Imaging Equipment), Application (Cardiology, Neu...
$ 3650
Medical Device Reprocessing Comprehensive Study by Application (Cardiology, Gastroenterology, Arthroscopy, Orthopedic, Anesthesia, Others), Device Type (Catheters, Laparoscopy Instruments, Biopsy Ins...
$ 3450